Jereme Sylvain, the Executive Vice President and Chief Financial Officer at DexCom Inc (NASDAQ: DXCM), has divested 3,363 shares of the company as per a recent disclosure to the Securities and Exchange Commission (SEC) on February 20, 2024. As of the recent insider sale date, DexCom Inc shares were trading at $116.73, translating to a market capitalization of $44.874 billion.
This move adds to a series of insider sales totaling 12,741 shares over the past year without any corresponding purchases. The insider transaction pattern within DexCom Inc. reveals a consistent trend of insider sales over the past year, with 53 sell-offs and no insider acquisitions recorded during this timeframe.
Jereme M. Sylvain’s estimated net worth surpasses $8 million as of February 23, 2024. Serving as the EVP CFO of DexCom Inc, Sylvain holds approximately 71,142 shares of DexCom Inc (DXCM) stock, valued at over $8 million.
DexCom Inc. specializes in pioneering continuous glucose monitoring (CGM) systems tailored for individuals managing diabetes. These innovative systems provide real-time glucose data, trends, and alerts, crucial for effectively managing blood sugar levels and mitigating diabetes-related risks.
Have you read?
Rebranding Countries: 17 Names That Redefined The Nation’s Identity.
These Are The Largest Warships In The World.
Ranked: Most Powerful Weapons in the World, 2023.
Ranked: Countries with the largest active combat helicopter fleet worldwide in 2023.
Ranked: Most powerful air forces in the World, 2023.
Report: Strongest Economies in The World in 2023.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
